Vanderbilt Clinical Trials

Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients

Purpose

This is an observational study that will monitor clinical outcomes of patients who have received a NiCord®/CordIn™ (omidubicel) transplant as part of a GC clinical interventional study and meet the eligibility criteria for this Long Term Follow Up study.

Condition

Patients Transplanted With NiCord/CordIn (Omidubicel)

Eligibility

Eligible Ages: Between 2 Years and 65 Years
Eligible Genders: All
Accepts Healthy Volunteers: No

Inclusion Criteria

Anyone who has received a NiCord®/CordIn™ (omidubicel) transplant, completed study specific follow up, and has signed the consent for this study.

Exclusion Criteria

None

Study Design

Phase
Study Type: Observational
Observational Model: Cohort
Time Perspective: Retrospective

Arm Groups

Arm	Description	Assigned Intervention
NiCord®/CordIn™ (omidubicel) transplanted	Anyone who signed the consent for this study received a NiCord®/CordIn™ (omidubicel) infusion as part of a GC clinical interventional study, and completed the interventional study Day 365 status assessment.	Genetic: NiCord®/CordIn™ (omidubicel)

More Details

Status: Completed
Sponsor: Gamida Cell ltd

Study Contact

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.